Vimarsana
Biggest News Aggregation in the World

Page 22 - Controlled Substances News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Substances. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Substances Today - Breaking & Trending Today

DEA Agrees To Reclassify Marijuana Under Federal Law, AP Reports - Vimarsana News

DEA Agrees To Reclassify Marijuana Under Federal Law, AP Reports

The DEA has agreed to reclassify marijuana under federal law, according to an Associated Press report on Tuesday.

Source: forbes.com
Marijuana Policy Project Reacts With Scepticism - Vimarsana News

Marijuana Policy Project Reacts With Scepticism

Matthew Schweich, executive director of the Marijuana Policy Project (MPP),described the move as a positive yet modest step

DOJ plans to move to reschedule marijuana as a lower-risk drug - Vimarsana News

DOJ plans to move to reschedule marijuana as a lower-risk drug

The Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, a historic move that acknowledges the medical benefits of the long-criminalized drug and carries broad implications for cannabis-related research and the industry at large.

Source: cnn.com
DEA plans to reschedule marijuana as a lower-risk drug - Vimarsana News

DEA plans to reschedule marijuana as a lower-risk drug

The Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans said.

Source: abc12.com
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana - Aurora Cannabis (NASDAQ:ACB), Cannabist Holdings (OTC:CBSTF) - Vimarsana News

Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana - Aurora Cannabis (NASDAQ:ACB), Cannabist Holdings (OTC:CBSTF)

The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move